Robin Smith - Insider Trading & Ownership

Location
C/O Phase III Medical, Inc., 330 South Service Road, Suite 120, Melville, NY
Summary
The estimated net worth of Robin Smith is at least $247K dollars as of May 2, 2025. Robin Smith is the Director of Sorrento Therapeutics, Inc. and owns shares of Sorrento Therapeutics, Inc. stock worth about $189K. Robin Smith is the Director of Celularity Inc and owns shares of Celularity Inc (CELU) stock worth about $58.8K.
Signature
/s/ Keith A. Kucinski, attorney-in fact for Robin Smith
All Insider Reports
All Insider Reports

Ownership of Robin Smith

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SRNEQ Sorrento Therapeutics, Inc. Director $189K Sep 3, 2021
CELU, CELUW Celularity Inc Director $58.8K Jun 14, 2023
MTNB Matinas BioPharma Holdings, Inc. Director Apr 30, 2025
CYCU, CYCUW Cycurion, Inc. Director Jan 11, 2022

Insider Transactions Reported by Robin Smith:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.